nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP1A2—chronic obstructive pulmonary disease	0.0485	0.18	CbGpPWpGaD
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP1A1—chronic obstructive pulmonary disease	0.0352	0.131	CbGpPWpGaD
Abacavir—UGT1A1—Heme degradation—HMOX1—chronic obstructive pulmonary disease	0.0138	0.0512	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.0137	0.0506	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.00992	0.0368	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00873	0.0324	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00863	0.032	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00726	0.0269	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00697	0.0258	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00605	0.0224	CbGpPWpGaD
Abacavir—UGT1A1—Porphyrin metabolism—HMOX1—chronic obstructive pulmonary disease	0.00601	0.0223	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.00556	0.0206	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—GSTM1—chronic obstructive pulmonary disease	0.00535	0.0198	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.00527	0.0195	CbGpPWpGaD
Abacavir—UGT1A1—Estrogen metabolism—CYP1A1—chronic obstructive pulmonary disease	0.00507	0.0188	CbGpPWpGaD
Abacavir—ADH6—Metabolism—APIP—chronic obstructive pulmonary disease	0.00424	0.0157	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A2—chronic obstructive pulmonary disease	0.00329	0.0122	CbGpPWpGaD
Abacavir—ADH6—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.00281	0.0104	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GC—chronic obstructive pulmonary disease	0.00273	0.0101	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.00272	0.0101	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00254	0.00941	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—CYP1A1—chronic obstructive pulmonary disease	0.00239	0.00886	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SOD3—chronic obstructive pulmonary disease	0.00239	0.00884	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GSTT1—chronic obstructive pulmonary disease	0.00236	0.00874	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—GCLC—chronic obstructive pulmonary disease	0.00233	0.00864	CbGpPWpGaD
Abacavir—ADK—Metabolism—APIP—chronic obstructive pulmonary disease	0.00226	0.00839	CbGpPWpGaD
Abacavir—UGT1A1—Phase II conjugation—CYP1A2—chronic obstructive pulmonary disease	0.00196	0.00726	CbGpPWpGaD
Abacavir—Immune system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00179	0.00246	CcSEcCtD
Abacavir—Chills—Salbutamol—chronic obstructive pulmonary disease	0.00178	0.00244	CcSEcCtD
Abacavir—Insomnia—Aminophylline—chronic obstructive pulmonary disease	0.00177	0.00244	CcSEcCtD
Abacavir—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.00174	0.0024	CcSEcCtD
Abacavir—Hypercholesterolaemia—Prednisone—chronic obstructive pulmonary disease	0.00174	0.00239	CcSEcCtD
Abacavir—Malnutrition—Salbutamol—chronic obstructive pulmonary disease	0.00172	0.00237	CcSEcCtD
Abacavir—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0017	0.00234	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—SERPINA1—chronic obstructive pulmonary disease	0.0017	0.0063	CbGpPWpGaD
Abacavir—Ill-defined disorder—Arformoterol—chronic obstructive pulmonary disease	0.00169	0.00233	CcSEcCtD
Abacavir—Ill-defined disorder—Formoterol—chronic obstructive pulmonary disease	0.00169	0.00233	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Tiotropium—chronic obstructive pulmonary disease	0.00168	0.00231	CcSEcCtD
Abacavir—Insomnia—Tiotropium—chronic obstructive pulmonary disease	0.00167	0.0023	CcSEcCtD
Abacavir—Paraesthesia—Tiotropium—chronic obstructive pulmonary disease	0.00166	0.00228	CcSEcCtD
Abacavir—Malaise—Arformoterol—chronic obstructive pulmonary disease	0.00165	0.00226	CcSEcCtD
Abacavir—Malaise—Formoterol—chronic obstructive pulmonary disease	0.00165	0.00226	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTP1—chronic obstructive pulmonary disease	0.00163	0.00606	CbGpPWpGaD
Abacavir—Gastrointestinal pain—Aminophylline—chronic obstructive pulmonary disease	0.0016	0.0022	CcSEcCtD
Abacavir—Ill-defined disorder—Salbutamol—chronic obstructive pulmonary disease	0.0016	0.0022	CcSEcCtD
Abacavir—Gastrointestinal disorder—Tiotropium—chronic obstructive pulmonary disease	0.00159	0.00219	CcSEcCtD
Abacavir—Cough—Formoterol—chronic obstructive pulmonary disease	0.00159	0.00219	CcSEcCtD
Abacavir—Cough—Arformoterol—chronic obstructive pulmonary disease	0.00159	0.00219	CcSEcCtD
Abacavir—Cough—Montelukast—chronic obstructive pulmonary disease	0.00156	0.00215	CcSEcCtD
Abacavir—Urticaria—Aminophylline—chronic obstructive pulmonary disease	0.00156	0.00214	CcSEcCtD
Abacavir—Malaise—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00214	CcSEcCtD
Abacavir—Myalgia—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00214	CcSEcCtD
Abacavir—Arthralgia—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00214	CcSEcCtD
Abacavir—Arthralgia—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00214	CcSEcCtD
Abacavir—Myalgia—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00214	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.00155	0.00576	CbGpPWpGaD
Abacavir—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.00155	0.00213	CcSEcCtD
Abacavir—Anxiety—Formoterol—chronic obstructive pulmonary disease	0.00155	0.00213	CcSEcCtD
Abacavir—Anxiety—Arformoterol—chronic obstructive pulmonary disease	0.00155	0.00213	CcSEcCtD
Abacavir—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.00155	0.00213	CcSEcCtD
Abacavir—Abdominal pain—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.00213	CcSEcCtD
Abacavir—Body temperature increased—Aminophylline—chronic obstructive pulmonary disease	0.00155	0.00213	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00212	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00212	CcSEcCtD
Abacavir—Neuropathy—Prednisone—chronic obstructive pulmonary disease	0.00154	0.00212	CcSEcCtD
Abacavir—Discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00154	0.00211	CcSEcCtD
Abacavir—Discomfort—Formoterol—chronic obstructive pulmonary disease	0.00154	0.00211	CcSEcCtD
Abacavir—Myalgia—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00209	CcSEcCtD
Abacavir—Arthralgia—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00209	CcSEcCtD
Abacavir—Anxiety—Montelukast—chronic obstructive pulmonary disease	0.00152	0.00209	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Montelukast—chronic obstructive pulmonary disease	0.00151	0.00208	CcSEcCtD
Abacavir—Gastrointestinal pain—Tiotropium—chronic obstructive pulmonary disease	0.00151	0.00208	CcSEcCtD
Abacavir—Cough—Salbutamol—chronic obstructive pulmonary disease	0.0015	0.00207	CcSEcCtD
Abacavir—UGT1A1—Phase II conjugation—GSTM1—chronic obstructive pulmonary disease	0.0015	0.00556	CbGpPWpGaD
Abacavir—ADK—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.0015	0.00556	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.00149	0.00553	CbGpPWpGaD
Abacavir—Oedema—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00205	CcSEcCtD
Abacavir—Oedema—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00205	CcSEcCtD
Abacavir—Anaphylactic shock—Arformoterol—chronic obstructive pulmonary disease	0.00149	0.00205	CcSEcCtD
Abacavir—Anaphylactic shock—Formoterol—chronic obstructive pulmonary disease	0.00149	0.00205	CcSEcCtD
Abacavir—Infection—Arformoterol—chronic obstructive pulmonary disease	0.00148	0.00204	CcSEcCtD
Abacavir—Infection—Formoterol—chronic obstructive pulmonary disease	0.00148	0.00204	CcSEcCtD
Abacavir—ADH6—Metabolism—GCLC—chronic obstructive pulmonary disease	0.00148	0.00547	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.00147	0.00546	CbGpPWpGaD
Abacavir—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00202	CcSEcCtD
Abacavir—Myalgia—Salbutamol—chronic obstructive pulmonary disease	0.00147	0.00202	CcSEcCtD
Abacavir—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.00147	0.00202	CcSEcCtD
Abacavir—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.00146	0.00201	CcSEcCtD
Abacavir—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.00146	0.00201	CcSEcCtD
Abacavir—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.00146	0.00201	CcSEcCtD
Abacavir—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.00146	0.00201	CcSEcCtD
Abacavir—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00201	CcSEcCtD
Abacavir—Oedema—Montelukast—chronic obstructive pulmonary disease	0.00146	0.00201	CcSEcCtD
Abacavir—ADK—Metabolism—GC—chronic obstructive pulmonary disease	0.00146	0.00541	CbGpPWpGaD
Abacavir—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00145	0.00199	CcSEcCtD
Abacavir—Infection—Montelukast—chronic obstructive pulmonary disease	0.00145	0.00199	CcSEcCtD
Abacavir—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.00145	0.00199	CcSEcCtD
Abacavir—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.00145	0.00199	CcSEcCtD
Abacavir—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.00145	0.00199	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.00145	0.00535	CbGpPWpGaD
Abacavir—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.00144	0.00198	CcSEcCtD
Abacavir—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00197	CcSEcCtD
Abacavir—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.00143	0.00197	CcSEcCtD
Abacavir—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.00142	0.00195	CcSEcCtD
Abacavir—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00193	CcSEcCtD
Abacavir—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.00141	0.00193	CcSEcCtD
Abacavir—Infection—Salbutamol—chronic obstructive pulmonary disease	0.0014	0.00192	CcSEcCtD
Abacavir—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.00139	0.00191	CcSEcCtD
Abacavir—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.00139	0.00191	CcSEcCtD
Abacavir—Pancreatitis—Prednisolone—chronic obstructive pulmonary disease	0.00139	0.00191	CcSEcCtD
Abacavir—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.00139	0.0019	CcSEcCtD
Abacavir—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.00138	0.0019	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.00138	0.00511	CbGpPWpGaD
Abacavir—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00137	0.00188	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.00136	0.00505	CbGpPWpGaD
Abacavir—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.00136	0.00187	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.00136	0.00187	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.00136	0.00187	CcSEcCtD
Abacavir—ADK—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00136	0.00503	CbGpPWpGaD
Abacavir—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.00135	0.00185	CcSEcCtD
Abacavir—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.00135	0.00185	CcSEcCtD
Abacavir—ADH6—Metabolism—CTGF—chronic obstructive pulmonary disease	0.00135	0.00499	CbGpPWpGaD
Abacavir—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.00134	0.00184	CcSEcCtD
Abacavir—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.00134	0.00184	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.00133	0.00183	CcSEcCtD
Abacavir—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.00133	0.00183	CcSEcCtD
Abacavir—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.00133	0.00183	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—chronic obstructive pulmonary disease	0.00132	0.0049	CbGpPWpGaD
Abacavir—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.00132	0.00182	CcSEcCtD
Abacavir—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.00131	0.00181	CcSEcCtD
Abacavir—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.00131	0.0018	CcSEcCtD
Abacavir—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.00131	0.0018	CcSEcCtD
Abacavir—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.00129	0.00178	CcSEcCtD
Abacavir—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.00129	0.00177	CcSEcCtD
Abacavir—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.00129	0.00177	CcSEcCtD
Abacavir—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.00128	0.00177	CcSEcCtD
Abacavir—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.00128	0.00177	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.00128	0.00176	CcSEcCtD
Abacavir—Pain—Formoterol—chronic obstructive pulmonary disease	0.00127	0.00175	CcSEcCtD
Abacavir—Pain—Arformoterol—chronic obstructive pulmonary disease	0.00127	0.00175	CcSEcCtD
Abacavir—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.00127	0.00175	CcSEcCtD
Abacavir—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.00126	0.00174	CcSEcCtD
Abacavir—ADH6—lung—chronic obstructive pulmonary disease	0.00126	0.442	CbGeAlD
Abacavir—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00173	CcSEcCtD
Abacavir—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.00126	0.00173	CcSEcCtD
Abacavir—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.00125	0.00173	CcSEcCtD
Abacavir—Pain—Montelukast—chronic obstructive pulmonary disease	0.00125	0.00172	CcSEcCtD
Abacavir—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.00125	0.00172	CcSEcCtD
Abacavir—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.00125	0.00171	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00124	0.0046	CbGpPWpGaD
Abacavir—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00171	CcSEcCtD
Abacavir—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.00124	0.00171	CcSEcCtD
Abacavir—Rash—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.0017	CcSEcCtD
Abacavir—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.0017	CcSEcCtD
Abacavir—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.00123	0.00169	CcSEcCtD
Abacavir—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.00123	0.00169	CcSEcCtD
Abacavir—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.00123	0.00169	CcSEcCtD
Abacavir—Headache—Aminophylline—chronic obstructive pulmonary disease	0.00123	0.00169	CcSEcCtD
Abacavir—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.00122	0.00168	CcSEcCtD
Abacavir—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00122	0.00168	CcSEcCtD
Abacavir—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.00122	0.00168	CcSEcCtD
Abacavir—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.00122	0.00168	CcSEcCtD
Abacavir—Lethargy—Prednisone—chronic obstructive pulmonary disease	0.00122	0.00167	CcSEcCtD
Abacavir—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00167	CcSEcCtD
Abacavir—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.00121	0.00167	CcSEcCtD
Abacavir—Pain—Salbutamol—chronic obstructive pulmonary disease	0.0012	0.00165	CcSEcCtD
Abacavir—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.00119	0.00164	CcSEcCtD
Abacavir—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00163	CcSEcCtD
Abacavir—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00163	CcSEcCtD
Abacavir—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00162	CcSEcCtD
Abacavir—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00162	CcSEcCtD
Abacavir—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.00118	0.00162	CcSEcCtD
Abacavir—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.00118	0.00162	CcSEcCtD
Abacavir—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.00117	0.00161	CcSEcCtD
Abacavir—Rash—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.0016	CcSEcCtD
Abacavir—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.0016	CcSEcCtD
Abacavir—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.00116	0.0016	CcSEcCtD
Abacavir—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.00116	0.00159	CcSEcCtD
Abacavir—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.00116	0.00159	CcSEcCtD
Abacavir—Headache—Tiotropium—chronic obstructive pulmonary disease	0.00116	0.00159	CcSEcCtD
Abacavir—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00159	CcSEcCtD
Abacavir—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.00115	0.00159	CcSEcCtD
Abacavir—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.00115	0.00158	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.00115	0.00425	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.00113	0.00419	CbGpPWpGaD
Abacavir—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.00112	0.00154	CcSEcCtD
Abacavir—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00153	CcSEcCtD
Abacavir—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.00111	0.00153	CcSEcCtD
Abacavir—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.0011	0.00151	CcSEcCtD
Abacavir—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.0011	0.00151	CcSEcCtD
Abacavir—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0011	0.00151	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.00109	0.00404	CbGpPWpGaD
Abacavir—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00108	0.00148	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.00107	0.00398	CbGpPWpGaD
Abacavir—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.00107	0.00147	CcSEcCtD
Abacavir—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.00107	0.00147	CcSEcCtD
Abacavir—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.00105	0.00145	CcSEcCtD
Abacavir—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.00105	0.00145	CcSEcCtD
Abacavir—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00145	CcSEcCtD
Abacavir—Alanine aminotransferase increased—Prednisone—chronic obstructive pulmonary disease	0.00105	0.00145	CcSEcCtD
Abacavir—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00105	0.00144	CcSEcCtD
Abacavir—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.00104	0.00143	CcSEcCtD
Abacavir—ADH6—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.00103	0.00383	CbGpPWpGaD
Abacavir—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.00103	0.00142	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TGFB1—chronic obstructive pulmonary disease	0.00103	0.00381	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.00102	0.00378	CbGpPWpGaD
Abacavir—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.00102	0.0014	CcSEcCtD
Abacavir—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.00102	0.0014	CcSEcCtD
Abacavir—Pancreatitis—Prednisone—chronic obstructive pulmonary disease	0.00101	0.00139	CcSEcCtD
Abacavir—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.00101	0.00139	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—chronic obstructive pulmonary disease	0.00101	0.00374	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.001	0.00371	CbGpPWpGaD
Abacavir—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000999	0.00137	CcSEcCtD
Abacavir—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000996	0.00137	CcSEcCtD
Abacavir—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000985	0.00136	CcSEcCtD
Abacavir—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000985	0.00136	CcSEcCtD
Abacavir—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000965	0.00133	CcSEcCtD
Abacavir—Neutropenia—Prednisone—chronic obstructive pulmonary disease	0.000964	0.00133	CcSEcCtD
Abacavir—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000963	0.00132	CcSEcCtD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—chronic obstructive pulmonary disease	0.00096	0.00356	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.000956	0.00354	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000951	0.00352	CbGpPWpGaD
Abacavir—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000948	0.0013	CcSEcCtD
Abacavir—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000948	0.0013	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000943	0.00349	CbGpPWpGaD
Abacavir—Rash—Formoterol—chronic obstructive pulmonary disease	0.00094	0.00129	CcSEcCtD
Abacavir—Rash—Arformoterol—chronic obstructive pulmonary disease	0.00094	0.00129	CcSEcCtD
Abacavir—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000939	0.00129	CcSEcCtD
Abacavir—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000939	0.00129	CcSEcCtD
Abacavir—Headache—Formoterol—chronic obstructive pulmonary disease	0.000934	0.00128	CcSEcCtD
Abacavir—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000934	0.00128	CcSEcCtD
Abacavir—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.000931	0.00128	CcSEcCtD
Abacavir—Hyperglycaemia—Prednisone—chronic obstructive pulmonary disease	0.00093	0.00128	CcSEcCtD
Abacavir—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000928	0.00128	CcSEcCtD
Abacavir—Rash—Montelukast—chronic obstructive pulmonary disease	0.00092	0.00127	CcSEcCtD
Abacavir—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.00092	0.00126	CcSEcCtD
Abacavir—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000918	0.00126	CcSEcCtD
Abacavir—Depression—Prednisone—chronic obstructive pulmonary disease	0.000917	0.00126	CcSEcCtD
Abacavir—Headache—Montelukast—chronic obstructive pulmonary disease	0.000914	0.00126	CcSEcCtD
Abacavir—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000907	0.00125	CcSEcCtD
Abacavir—ADH6—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000902	0.00334	CbGpPWpGaD
Abacavir—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.000901	0.00124	CcSEcCtD
Abacavir—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.000901	0.00124	CcSEcCtD
Abacavir—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000895	0.00123	CcSEcCtD
Abacavir—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000892	0.00123	CcSEcCtD
Abacavir—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000888	0.00122	CcSEcCtD
Abacavir—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000887	0.00122	CcSEcCtD
Abacavir—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000886	0.00122	CcSEcCtD
Abacavir—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000885	0.00122	CcSEcCtD
Abacavir—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000885	0.00122	CcSEcCtD
Abacavir—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000882	0.00121	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000879	0.00326	CbGpPWpGaD
Abacavir—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000867	0.00119	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000867	0.00321	CbGpPWpGaD
Abacavir—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.000857	0.00118	CcSEcCtD
Abacavir—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000836	0.00115	CcSEcCtD
Abacavir—UGT1A1—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000833	0.00309	CbGpPWpGaD
Abacavir—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000832	0.00114	CcSEcCtD
Abacavir—UGT1A1—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.000821	0.00304	CbGpPWpGaD
Abacavir—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000811	0.00112	CcSEcCtD
Abacavir—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000807	0.00111	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000807	0.00111	CcSEcCtD
Abacavir—ADK—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000797	0.00295	CbGpPWpGaD
Abacavir—ADK—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000788	0.00292	CbGpPWpGaD
Abacavir—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000746	0.00103	CcSEcCtD
Abacavir—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.00073	0.001	CcSEcCtD
Abacavir—Alopecia—Prednisone—chronic obstructive pulmonary disease	0.000729	0.001	CcSEcCtD
Abacavir—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000725	0.000997	CcSEcCtD
Abacavir—ADK—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000719	0.00266	CbGpPWpGaD
Abacavir—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000719	0.000988	CcSEcCtD
Abacavir—Pain—Prednisolone—chronic obstructive pulmonary disease	0.00069	0.000949	CcSEcCtD
Abacavir—UGT1A1—Metabolism—APIP—chronic obstructive pulmonary disease	0.00067	0.00248	CbGpPWpGaD
Abacavir—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000667	0.000917	CcSEcCtD
Abacavir—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000665	0.000915	CcSEcCtD
Abacavir—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000664	0.000913	CcSEcCtD
Abacavir—ADK—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000663	0.00245	CbGpPWpGaD
Abacavir—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000648	0.000891	CcSEcCtD
Abacavir—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000646	0.000888	CcSEcCtD
Abacavir—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000641	0.000882	CcSEcCtD
Abacavir—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.000623	0.000856	CcSEcCtD
Abacavir—ADH6—Metabolism—ALB—chronic obstructive pulmonary disease	0.000613	0.00227	CbGpPWpGaD
Abacavir—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.000612	0.000841	CcSEcCtD
Abacavir—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.000612	0.000841	CcSEcCtD
Abacavir—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00061	0.000838	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000608	0.000835	CcSEcCtD
Abacavir—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000604	0.000831	CcSEcCtD
Abacavir—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000595	0.000818	CcSEcCtD
Abacavir—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000586	0.000806	CcSEcCtD
Abacavir—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000586	0.000806	CcSEcCtD
Abacavir—ADH6—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000586	0.00217	CbGpPWpGaD
Abacavir—Infection—Prednisone—chronic obstructive pulmonary disease	0.000583	0.000801	CcSEcCtD
Abacavir—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000575	0.000791	CcSEcCtD
Abacavir—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.00057	0.000783	CcSEcCtD
Abacavir—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000559	0.000769	CcSEcCtD
Abacavir—ADK—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000553	0.00205	CbGpPWpGaD
Abacavir—ADK—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000545	0.00202	CbGpPWpGaD
Abacavir—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000534	0.000735	CcSEcCtD
Abacavir—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000534	0.000734	CcSEcCtD
Abacavir—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.00053	0.000729	CcSEcCtD
Abacavir—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000527	0.000724	CcSEcCtD
Abacavir—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00051	0.000701	CcSEcCtD
Abacavir—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000509	0.0007	CcSEcCtD
Abacavir—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000508	0.000699	CcSEcCtD
Abacavir—ADK—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.000508	0.00188	CbGpPWpGaD
Abacavir—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000506	0.000695	CcSEcCtD
Abacavir—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000506	0.000695	CcSEcCtD
Abacavir—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000483	0.000665	CcSEcCtD
Abacavir—ADK—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000481	0.00178	CbGpPWpGaD
Abacavir—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.00048	0.000659	CcSEcCtD
Abacavir—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000479	0.000659	CcSEcCtD
Abacavir—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.000466	0.000641	CcSEcCtD
Abacavir—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000464	0.000637	CcSEcCtD
Abacavir—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000464	0.000637	CcSEcCtD
Abacavir—ADK—bronchus—chronic obstructive pulmonary disease	0.000453	0.159	CbGeAlD
Abacavir—UGT1A1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000444	0.00164	CbGpPWpGaD
Abacavir—ADK—smooth muscle tissue—chronic obstructive pulmonary disease	0.000443	0.155	CbGeAlD
Abacavir—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000432	0.000594	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GC—chronic obstructive pulmonary disease	0.000432	0.0016	CbGpPWpGaD
Abacavir—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000421	0.000579	CcSEcCtD
Abacavir—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000415	0.000571	CcSEcCtD
Abacavir—UGT1A1—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000408	0.00151	CbGpPWpGaD
Abacavir—ADK—trachea—chronic obstructive pulmonary disease	0.000407	0.142	CbGeAlD
Abacavir—UGT1A1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000401	0.00149	CbGpPWpGaD
Abacavir—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000401	0.000552	CcSEcCtD
Abacavir—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000388	0.000533	CcSEcCtD
Abacavir—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000373	0.000513	CcSEcCtD
Abacavir—Rash—Prednisone—chronic obstructive pulmonary disease	0.00037	0.000508	CcSEcCtD
Abacavir—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000369	0.000508	CcSEcCtD
Abacavir—Headache—Prednisone—chronic obstructive pulmonary disease	0.000367	0.000505	CcSEcCtD
Abacavir—Nausea—Prednisone—chronic obstructive pulmonary disease	0.000348	0.000479	CcSEcCtD
Abacavir—ADK—Metabolism—ALB—chronic obstructive pulmonary disease	0.000327	0.00121	CbGpPWpGaD
Abacavir—ADK—Metabolism—NOS3—chronic obstructive pulmonary disease	0.000313	0.00116	CbGpPWpGaD
Abacavir—ADK—lung—chronic obstructive pulmonary disease	0.000292	0.102	CbGeAlD
Abacavir—UGT1A1—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.000236	0.000874	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GCLC—chronic obstructive pulmonary disease	0.000233	0.000864	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CTGF—chronic obstructive pulmonary disease	0.000213	0.000788	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	0.000196	0.000726	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTP1—chronic obstructive pulmonary disease	0.000164	0.000606	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HMOX1—chronic obstructive pulmonary disease	0.000161	0.000597	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GSTM1—chronic obstructive pulmonary disease	0.00015	0.000557	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000142	0.000528	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—chronic obstructive pulmonary disease	9.68e-05	0.000359	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NOS3—chronic obstructive pulmonary disease	9.26e-05	0.000343	CbGpPWpGaD
